SUSTAINED IMPROVEMENT OF RENAL GRAFT FUNCTION FOR TWO YEARS IN HYPERTENSIVE RENAL TRANSPLANT RECIPIENTS TREATED WITH NIFEDIPINE AS COMPARED TO LISINOPRIL1
- 1 December 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Transplantation
- Vol. 72 (11) , 1787-1792
- https://doi.org/10.1097/00007890-200112150-00013
Abstract
Treatment of posttransplant hypertension is still a matter of debate. Calcium antagonists may ameliorate renal side effects of cyclosporin. Angiotensin converting enzyme- (ACE) inhibitors may be more effective in sustaining renal function in native chronic renal disease. We prospectively compared the effect of controlled release nifedipine and lisinopril on long-term renal function in hypertensive kidney transplant patients treated with cyclosporin. A total of 154 renal transplant patients presenting with hypertension (diastolic blood pressure ≥95 mmHg) during the first 3 weeks after transplantation were randomised to receive double-blind nifedipine 30 mg or lisinopril 10 mg once daily. A total of 123 patients completed 1 year of treatment (69 nifedipine, 54 lisinopril) and 64 patients completed 2 years of double-blind treatment (39 nifedipine, 25 lisinopril). Baseline glomerular filtration rate was measured as 99 mTc-diethylene-triaminepentaacetate clearance in a stable phase 2 to 5 weeks after inclusion and repeated at 1 and 2 years. Baseline glomerular filtration rates were similar (46±16 ml/min with nifedipine, 43±14 ml/min with lisinopril). The changes in glomerular filtration rates from baseline were statistically significant between the groups after 1 year (9.6 ml/min mean treatment difference (95% confidence interval [CI]s 5.5–13.7 ml/min, P =0.0001) and remained statistically significant also after 2 years (10.3 ml/min mean difference (95% CIs 4.0–16.6], P =0.0017). After 1 year glomerular filtration rates averaged 56±19 ml/min in the nifedipine group and 44±14 ml/min in the lisinopril group. Both nifedipine and lisinopril were safe and effective in treatment of hypertension in renal transplant patients treated with cyclosporin. Patients receiving nifedipine but not lisinopril improved kidney transplant function over a period of 2 years.Keywords
This publication has 22 references indexed in Scilit:
- Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: a randomised trialThe Lancet, 1999
- Association of chronic kidney graft failure with recipient blood pressureKidney International, 1998
- Blood Pressure and End-Stage Renal Disease in MenNew England Journal of Medicine, 1996
- Hypertension After Renal TransplantationHypertension, 1995
- Long-Term Efficacy and Safety of Cyclosporine in Renal-Transplant RecipientsNew England Journal of Medicine, 1994
- THE IMPACT OF AN ACUTE REJECTION EPISODE ON LONG-TERM RENAL ALLOGRAFT SURVIVAL (t1/2)1,2Transplantation, 1994
- Hypertension after renal transplantation.Journal of the American Society of Nephrology, 1994
- THE IMPACT OF ACUTE REJECTION EPISODES ON LONG-TERM GRAFT FUNCTION AND OUTCOME IN 1347 PRIMARY RENAL TRANSPLANTS TREATED BY 3 CYCLOSPORINE REGIMENSTransplantation, 1993
- The Role of Hypertension as a Damaging Factor for Kidney Grafts Under Cyclosporine TherapyAmerican Journal of Kidney Diseases, 1993
- Hypertension After Renal TransplantationAmerican Journal of Kidney Diseases, 1993